JND’s CEO Jennifer Keough and her team, including JND Vice President Gretchen Eoff, were designated as the escrow agent and claims processor in the $1 billion settlement in In re Stryker Rejuvenate and ABG II Hip Implant Products Liab. Litig., No. 13-2441 (MDL) (D. Minn.). The settlement was structured to compensate eligible U.S. Patients who had surgery to replace their Rejuvenate Modular-Neck and/or ABG II Modular-Neck hip stems prior to November 3, 2014. As the claims processor, Ms. Keough and her team designed internal procedures to ensure the accurate review of all medical documentation received; designed an interactive website which included online claim filing; and established a toll-free number to allow class members to receive information about the settlement 24 hours a day. Additionally, she oversaw the creation of a deficiency process to ensure claimants were notified of their deficient submission and provided an opportunity to cure. The program also included an auditing procedure designed to detect fraudulent claims and a process for distributing initial and supplemental payments. Approximately 95% of the registered eligible patients enrolled in the settlement program.